INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 42h ago
HOUSE PTR2h ago
SEC 13F2h ago
ROBINHOOD CHAIN2h ago
Corporate insider
PE

Pelish Henry E.

Chief Scientific OfficerCIK 0002029477

EDGAR filingsOpen in network
Disclosed transactions18
Buys / sells0 / 8
Max Insider Score32
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
4
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
3,093 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Nuvalent, Inc.Chief Scientific Officer · Mar 16, 2026
0
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M
$86K
3,093 sh
Apr 9, 2026
Apr 13, 2026
traded Apr 9, 2026
+4d
SEC FORM 4

Evidence

16
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$95K
900 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

16
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$229K
2,193 sh
Apr 9, 2026Apr 13, 2026
traded Apr 9, 2026
+4dSEC FORM 4

Evidence

0
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$49K
1,754 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

2
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$216K
2,985 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

32
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$2.37M
24.2K sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

25
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$542K
5,505 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

15
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$30K
306 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

14
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$79K
804 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC FORM 4

Evidence

17
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$257K
2,597 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC FORM 4

Evidence

14
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Open-market sale · 10b5-1 plan
SELL$170K
1,703 sh
Mar 13, 2026Mar 16, 2026
traded Mar 13, 2026
+3dSEC FORM 4

Evidence

3
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
1,754 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

0
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
8,456 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

3
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
2,985 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

2
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$121K
4,125 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

11
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M—
4,125 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence

6
PE
Pelish Henry E.Chief Scientific Officer
NUVLNuvalent, Inc.
Option exercise · 10b5-1 plan
M$160K
8,456 sh
Mar 12, 2026Mar 16, 2026
traded Mar 12, 2026
+4dSEC FORM 4

Evidence